Saudi Arabia vs South Sudan: Treatment success rate for patients treated for MDR-TB
Saudi Arabia
93.0%
in 2022
South Sudan
94.0%
in 2022
Saudi Arabia rank
20th
South Sudan rank
19th
Treatment success rate for patients treated for MDR-TB over time
- Saudi Arabia
- South Sudan
How they compare
South Sudan currently reports 94.0% against 93.0% in Saudi Arabia, a difference of 1.0%.
Across all 6 years both countries report, South Sudan has been ahead every year.
Saudi Arabia ranks 20th and South Sudan ranks 19th of 163 countries.
South Sudan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Saudi Arabia | South Sudan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 78.3% | 87.7% | 9.3% | South Sudan |
| 2020s | 81.0% | 93.0% | 12.0% | South Sudan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Saudi Arabia or South Sudan?
- South Sudan, at 94.0% against 93.0% in Saudi Arabia as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Saudi Arabia and South Sudan?
- 1.0%, with South Sudan ahead.
- How many years of comparable data are there for Saudi Arabia and South Sudan?
- 6 years are reported by both, from 2017 to 2022.
- How do Saudi Arabia and South Sudan rank globally for treatment success rate for patients treated for mdr-tb?
- Saudi Arabia ranks 20th and South Sudan ranks 19th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.